Founded in 2018, AZmed is a multicultural company dedicated to enhancing physicians' workflows by integrating artificial intelligence. Starting with a small team, it successfully secured funding in 2019, expanding to 10 diverse members. In 2020, AZmed launched Rayvolve, an AI-driven fracture detection product for X-rays, which by 2022 received CE and FDA clearance and was adopted in 25 countries. The company operates across 10 nations, growing its team to over 35 by 2023 and structuring multiple product verticals. Valuing continuous improvement, responsibility, and open-mindedness, AZmed strives to support clinicians and patients alike. In 2024, recognized as a leader in AI for medical imaging, AZmed announced a €15 million fundraising, reinforcing its commitment to optimizing medical workflows and care quality.